Call for papers
Camila Corvalán, MD, MPH, PhD, University of Chile, Chile
Jasmine Fledderjohann, PhD, Lancaster University, UK
Marisa Miraldo, PhD, Imperial College Business School, UK
Paraskevi Seferidi, PhD, Imperial College London, UK
Submission Status: Open until 6 November 2024
Shanquan Chen: The London School of Hygiene & Tropical Medicine, London, UK
Feng Sha: Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China
Zhirong Yang: Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China
Submission Status: Open until 31 January 2024
Michael Absoud: King's College London, United Kingdom
Victoria Cosgrove: Stanford University, United States
Kirsty Donald: University of Cape Town, South Africa
Submission Status: Open until 31 March 2024
Modelling the effects of structural interventions and social enablers on HIV incidence and mortality in sub-Saharan African countries
Charles Birungi: UNAIDS, Uganda
Timothy Hallett: Imperial College London, UK
Anne Stangl: Centers for Disease Control and Prevention, USA
Submission Status: Open until 15 February 2024
We are seeking submissions on pain in vulnerable groups, especially content from low-middle income and vulnerable population settings so relevant communities are heard and served. Guest Edited by pediatric and geriatric key opinion leaders.
We are pleased to launch this new article collection which will welcome novel and insightful papers that have an impact on our understanding of Dementia, it's prevention and therapies.
BMC Medicine is now welcoming articles that contribute to our understanding of how maternal factors can influence outcomes for both mother and child, as well as identifying novel factors that mediate these effects.
Heart failure with preserved ejection fraction: a widespread unmet need for translational research and clinical management
This Call for papers has closed, and the Article Collection will soon be published on recent translational and clinical findings on HFpEF, controversies and future perspectives.
BMC Medicine and BMC Cancer are welcoming submissions to a new joint collection on cancer targeted therapies, including novel therapies, treatment resistance, combination therapies and biomarker discovery.
Taking on the challenge: Food sensitivity, intolerance and altered microbiota in irritable bowel syndrome
We are seeking submissions on all novel, impactful advances of irritable bowel syndrome, including disease burden, etiology, pathophysiology, and therapies.
We are seeking submissions on all novel, impactful advances of diabetic kidney disease, including disease burden, etiology, pathophysiology, and therapies.